VU 0357121 25 mg | 99.99%
TargetMol
VU0357121, a positive allosteric modulator of mGlu5 (EC50: 33 nM), is inactive or very weakly antagonizing at other mGlu receptor subtypes.
More Information Supplier Page
VU0357121, a positive allosteric modulator of mGlu5 (EC50: 33 nM), is inactive or very weakly antagonizing at other mGlu receptor subtypes.
More Information Supplier Page
VU0357121, a positive allosteric modulator of mGlu5 (EC50: 33 nM), is inactive or very weakly antagonizing at other mGlu receptor subtypes.
More Information Supplier Page
Scopine, the metabolite of anisodine, is an α1-adrenergic receptor agonist used in the therapy of acute circulatory shock.
More Information Supplier Page
Scopine, the metabolite of anisodine, is an α1-adrenergic receptor agonist used in the therapy of acute circulatory shock.
More Information Supplier Page
Scopine, the metabolite of anisodine, is an α1-adrenergic receptor agonist used in the therapy of acute circulatory shock.
More Information Supplier Page
BI-78D3, a competitive JNK inhibitor. IC50 of BI-78D3 is 280 nM that displays > 100 fold selectivity over p38α, and have no activity at mTOR and PI-3K.
More Information Supplier Page
BI-78D3, a competitive JNK inhibitor. IC50 of BI-78D3 is 280 nM that displays > 100 fold selectivity over p38α, and have no activity at mTOR and PI-3K.
More Information Supplier Page
Dyngo-4a , a effective dynamin inhibitor, inhibits withDynI (brain), DynI (rec), and DynII (rec) of IC50 of 0.38 μM, 1.1 μM, and 2.3 μM, respectively.
More Information Supplier Page